Unknown

Dataset Information

0

LYTACs that engage the asialoglycoprotein receptor for targeted protein degradation.


ABSTRACT: Selective protein degradation platforms have afforded new development opportunities for therapeutics and tools for biological inquiry. The first lysosome-targeting chimeras (LYTACs) targeted extracellular and membrane proteins for degradation by bridging a target protein to the cation-independent mannose-6-phosphate receptor (CI-M6PR). Here, we developed LYTACs that engage the asialoglycoprotein receptor (ASGPR), a liver-specific lysosome-targeting receptor, to degrade extracellular proteins in a cell-type-specific manner. We conjugated binders to a triantenerrary N-acetylgalactosamine (tri-GalNAc) motif that engages ASGPR to drive the downregulation of proteins. Degradation of epidermal growth factor receptor (EGFR) by GalNAc-LYTAC attenuated EGFR signaling compared to inhibition with an antibody. Furthermore, we demonstrated that a LYTAC consisting of a 3.4-kDa peptide binder linked to a tri-GalNAc ligand degrades integrins and reduces cancer cell proliferation. Degradation with a single tri-GalNAc ligand prompted site-specific conjugation on antibody scaffolds, which improved the pharmacokinetic profile of GalNAc-LYTACs in vivo. GalNAc-LYTACs thus represent an avenue for cell-type-restricted protein degradation.

SUBMITTER: Ahn G 

PROVIDER: S-EPMC8387313 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6535107 | biostudies-literature
| S-EPMC10347610 | biostudies-literature
| S-EPMC8244555 | biostudies-literature
| S-EPMC9181004 | biostudies-literature
| S-EPMC9266413 | biostudies-literature
| S-EPMC5009246 | biostudies-literature
| S-EPMC5680813 | biostudies-literature
2022-06-26 | GSE206612 | GEO
| S-EPMC2856979 | biostudies-literature
| S-EPMC10127205 | biostudies-literature